Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (18)

2013

  1. Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure

    Journal of Hypertension, Vol. 31, Núm. 11, pp. 2309-2319

2010

  1. Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes

    Diabetes, Vol. 59, Núm. 6, pp. 1292-1301

2006

  1. Losartan improves resistance artery lesions and prevents CTGF and TGF-β production in mild hypertensive patients

    Kidney International, Vol. 69, Núm. 7, pp. 1237-1244

2001

  1. Activation of NF-κB in tubular epithelial cells of rats with intense proteinuria role of angiotensin II and endothelin-1

    Hypertension, Vol. 37, Núm. 4, pp. 1171-1178

  2. Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition

    American Journal of Physiology - Renal Physiology, Vol. 281, Núm. 1 50-1

  3. Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: Role of endothelin-1

    American Journal of Pathology, Vol. 159, Núm. 5, pp. 1895-1904

1999

  1. Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria

    Hypertension, Vol. 33, Núm. 2, pp. 732-739

1997

  1. Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin- converting enzyme inhibitor quinapril

    Hypertension, Vol. 29, Núm. 5, pp. 1178-1185

  2. Platelet-activating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: Role of TGF-β

    Journal of the American Society of Nephrology, Vol. 8, Núm. 8, pp. 1266-1275

  3. Quinapril decreases renal endothelin-1 expression and synthesis in a normotensive model of immune-complex nephritis

    Journal of the American Society of Nephrology, Vol. 8, Núm. 5, pp. 756-768

1996

  1. An orally active ET(A)/ET(B) receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis

    Kidney International, Vol. 50, Núm. 3, pp. 962-972

  2. Citoquinas profibrogenicas y angiotensina II en la patogenia de la esclerosis renal

    Nefrologia

  3. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth

    Hypertension, Vol. 27, Núm. 4, pp. 885-892

  4. Endothelin-1 induces loss of proteoglycans and enhances fibronectin and collagen production in cultured rabbit synovial cells

    European Journal of Pharmacology, Vol. 302, Núm. 1-3, pp. 191-197

1995

  1. Potential factors governing extracellular matrix production by mesangial cells: their relevance for the pathogenesis of IgA nephropathy.

    Contributions to nephrology, Vol. 111, pp. 45-54

1994

  1. Involvement of angiotensin ii and endothelin in matrix protein production and renal sclerosis

    Journal of Hypertension, Vol. 12, pp. S51-S58

  2. The potential role of inflammatory and fibrogenic cytokines in the glomerular diseases

    Journal of Lipid Mediators and Cell Signalling, Vol. 9, Núm. 1, pp. 55-74

1992

  1. Aggregation of human polymorphonuclear leukocytes by endothelin: role of platelet-activating factor

    European Journal of Pharmacology, Vol. 224, Núm. 2-3, pp. 167-172